Propel Bio Management »

Eyepoint Pharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 216k 12.92

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
Cormorant Asset Management
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
Adage Capital Partners GP
Henderson Group
Vanguard Capital Management
Paradigm Biocapital Advisors
Commodore Capital
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen

View all funds holding Eyepoint Pharmaceuticals